Skip to main content

Table 1 Preoperative demographics and clinical data (preoperative prognostic factors) in the 189 patients with HCC

From: Onodera’s prognostic nutritional index is a strong prognostic indicator for patients with hepatocellular carcinoma after initial hepatectomy, especially patients with preserved liver function

Variables  
Age (years) 70 (41–85)
Sex (male/female) 153 (81%)/36 (19%)
BMI 22.1 (13.2–34.5)
Lymphocyte count (/mm3) 1400 (320–3950)
Neutrophil count (/mm3) 3020 (820–8780)
Platelet count (103/µl) 18.3 (4.1–219.0)
Albumin (g/dl) 3.8 (2.3–5.3)
Total bilirubin (mg/dl) 0.6 (0.2–2.5)
PT-INR 1.05 (0.87–1.41)
Child–Pugh A/B/C 178 (94.2%) / 11 (5.8%) / 0
AFP (ng/ml) 12 (1–253,875)
DCP (mAU/ml) 115 (1–286,400)
ICG R15 (%) 12.9 (0.3–76.3)
LHL15 0.935 (0.679–0.987)
Tumor size (cm) 4.0 (0.5–24.0)
Multiple tumor 49 (25.9%)
BCLC stage 0/A/B/C 17 / 121 / 38 / 13
Milan criteria within / beyond 107 (56.6%) / 82 (43.4%)
PNI 45.4 (26.0–60.0)
NLR 2.06 (0.52–14.2)
PLR 135 (33–1685)
ALBI grade 1 / 2 / 3 85 (45%) / 99 (52%) / 5 (3%)
Underlying liver disease  
 NBNC / HBV / HCV 85 (45%) / 26 (14%) / 78 (41%)
  1. BMI body mass index, PNI prognostic nutritional index, PT-INR prothrombin time-international normalized ratio, AFP alpha fetoprotein, DCP des-γ-carboxyprothrombin, ICGR15 indocyanine green retention rate at 15 min, LHL15 GSA uptake ratio of the liver to the liver plus heart at 15 min, BCLC stage Barcelona Clinic Liver Cancer stage, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio, ALBI grade albumin-bilirubin grade, NBNC non-B non-C, HBV hepatits B, HCV hepatitis C